RPTX
Repare Therapeutics Inc. Common Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
RPTX Stock Analysis: Buy, Sell, or Hold?
$2.65
+0.02 (+0.76%)
â˛
5d:
+2.71%
30d:
+3.31%
90d:
+35.2%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (67%)
Quality Score
48/100
Position
FAIR
Forward P/E & Valuation
-3.6x
Next 12M consensus est.
Wall Street Target
$3.00
+13.2% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$2.50 / $2.65
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: RPTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When RPTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: RPTX is currently trading at $2.65, which is considered fair based on recent price action.
Technical Outlook: Technically, RPTX is in a strong uptrend. The price is approaching resistance at $2.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.00 (+13.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RPTX is in a strong uptrend. The price is approaching resistance at $2.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.00 (+13.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
48/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
66.8%
Trading Range & Key Levels
Support Level
$2.50
Resistance Level
$2.65
Current Trend
Strong Uptrend
Technical data as of
Jan 27, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Trading below Wall St target ($3.00)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.63
Wall Street Target
$3.00
(+13.2%)
Revenue Growth (YoY)
-76.7%
Share RPTX Analysis
Share this live RPTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (RPTX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jan 23, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user estimates a potential value of $46 per CVR of $RPTX based on asset sales and commercial catalysts, despite the lack of new news articles.
Key Retail Themes:
Asset Sales and Commercial Catalysts
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:11 PM ET
Data refreshes hourly during market hours. Next update: 9:11 PM
Data refreshes hourly during market hours. Next update: 9:11 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RPTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive RPTX Research Pages
